Rayonier Advanced Materials (NYSE:RYAM) Stock Passes Below Fifty Day Moving Average – Here’s What Happened

Rayonier Advanced Materials Inc. (NYSE:RYAMGet Free Report)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $9.67 and traded as low as $9.41. Rayonier Advanced Materials shares last traded at $9.9050, with a volume of 777,318 shares.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Rayonier Advanced Materials in a report on Thursday, January 22nd. Wall Street Zen raised Rayonier Advanced Materials from a “sell” rating to a “hold” rating in a report on Saturday, February 21st. Finally, Royal Bank Of Canada boosted their target price on Rayonier Advanced Materials from $9.00 to $14.00 and gave the stock an “outperform” rating in a report on Thursday, March 5th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Rayonier Advanced Materials currently has an average rating of “Hold” and an average price target of $14.00.

Get Our Latest Report on Rayonier Advanced Materials

Rayonier Advanced Materials Trading Down 1.1%

The company has a debt-to-equity ratio of 2.39, a quick ratio of 0.92 and a current ratio of 1.58. The business has a fifty day simple moving average of $9.71 and a 200 day simple moving average of $7.86. The stock has a market capitalization of $675.58 million, a price-to-earnings ratio of -1.59 and a beta of 2.03.

Rayonier Advanced Materials (NYSE:RYAMGet Free Report) last issued its quarterly earnings data on Tuesday, March 3rd. The basic materials company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.19). Rayonier Advanced Materials had a negative net margin of 28.65% and a negative return on equity of 19.70%. The firm had revenue of $417.55 million during the quarter, compared to analyst estimates of $364.07 million. As a group, research analysts expect that Rayonier Advanced Materials Inc. will post -0.08 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RYAM. Tudor Investment Corp ET AL bought a new stake in shares of Rayonier Advanced Materials during the 4th quarter valued at $126,000. Numerai GP LLC bought a new stake in shares of Rayonier Advanced Materials during the 4th quarter valued at $418,000. Cinctive Capital Management LP bought a new stake in shares of Rayonier Advanced Materials during the 4th quarter valued at $187,000. Balyasny Asset Management L.P. bought a new stake in shares of Rayonier Advanced Materials during the 4th quarter valued at $117,000. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Rayonier Advanced Materials by 13.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 39,121 shares of the basic materials company’s stock valued at $231,000 after acquiring an additional 4,714 shares during the period. 68.64% of the stock is owned by institutional investors and hedge funds.

About Rayonier Advanced Materials

(Get Free Report)

Rayonier Advanced Materials, Inc is a publicly traded specialty bioproducts company focused on the production of high-purity cellulose and engineered wood products. Headquartered in Jacksonville, Florida, the company operates a network of manufacturing facilities across North America, New Zealand and Europe. Its cellulose specialties business produces dissolving pulps and high-purity fibers that serve a range of end markets, including food and beverage, personal care, pharmaceuticals and textiles.

Read More

Receive News & Ratings for Rayonier Advanced Materials Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rayonier Advanced Materials and related companies with MarketBeat.com's FREE daily email newsletter.